# Results of a randomized, placebo-controlled, phase 2 study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/results-of-a-randomized-placebo-controlled-phase-2-study-of-tarextumab-trxt-anti/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Davey B. Daniel,Charles M. Rudin,L. Hart,David R. Spigel,Martin J. Edelman,Jerome H. Goldschmidt,Rodolfo Bordoni,Bonnie S. Glisson,Timothy F. Burns,Afshin Dowlati,Grace K. Dy,Thaddeus Beck,Robert M. Jotte,Stephen V. Liu,Ann M. Kapoun,L. Faoro,Anne C. Chiang |
| Citations | 18 |
| DOI | 10.1093/annonc/mdx386.004 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2761332640 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Afshin Dowlati](https://scholariq.org/researchers/afshin-dowlati/)
- [Martin J. Edelman](https://scholariq.org/researchers/martin-j-edelman/)
- [Bonnie S. Glisson](https://scholariq.org/researchers/bonnie-s-glisson/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.